Form 8-K - Current report:
SEC Accession No. 0000950170-25-063954
Filing Date
2025-05-06
Accepted
2025-05-06 07:05:10
Documents
12
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K upb-20250506.htm   iXBRL 8-K 45586
2 EX-99.1 upb-ex99_1.htm EX-99.1 184435
  Complete submission text file 0000950170-25-063954.txt   363176

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT upb-20250506.xsd EX-101.SCH 26961
14 EXTRACTED XBRL INSTANCE DOCUMENT upb-20250506_htm.xml XML 5106
Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Filer) CIK: 0002022626 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42366 | Film No.: 25915193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)